The journey started with an enigma in the zebrafish embryo: some endothelial cells, actively involved in the initial stages ...

Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine, advance its pipeline, and expand its headcount in its first external funding ...

Discover why Alphabet Inc.'s AI-driven growth and new revenue streams could mean its shares remain undervalued. Click for ...

Alphabet is emerging as the true ChatGPT Killer by embedding Gemini directly into the daily workflow of billions of users.

Iambic, a clinical-stage life science and technology company that uses artificial intelligence to develop medicines has ...

Rachel Warren has positions in Alphabet and Amazon. The Motley Fool has positions in and recommends Alphabet, Amazon, GitLab, Microsoft, and Snowflake. The Motley Fool recommends the following options ...

In an interview with the Post, founder and president Ronald Sun expressed confidence that IntelliGen AI could soon compete globally with Isomorphic Labs, a spin-off of DeepMind, in leveraging AI for ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human? Reading time 3 ...

Alphabet’s Isomorphic Labs is preparing to begin the first human clinical trials of a drug designed with the help of artificial intelligence, according to company leadership. The UK-based firm, which ...

Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper and ...

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial Intelligence. Isomorphic Labs, a drug discovery company spun out of Google DeepMind, ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...